Published in J Bacteriol on April 01, 1992
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect Immun (2003) 2.69
Vibrio cholerae O1 strain TSI-4 produces the exopolysaccharide materials that determine colony morphology, stress resistance, and biofilm formation. Appl Environ Microbiol (1998) 2.68
OpaR, a homolog of Vibrio harveyi LuxR, controls opacity of Vibrio parahaemolyticus. J Bacteriol (1998) 1.91
Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates. Appl Environ Microbiol (1996) 1.72
Multiple Vibrio vulnificus strains in oysters as demonstrated by clamped homogeneous electric field gel electrophoresis. Appl Environ Microbiol (1995) 1.62
Relation of capsular polysaccharide production and colonial cell organization to colony morphology in Vibrio parahaemolyticus. J Bacteriol (2000) 1.59
Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun (2001) 1.58
Differential expression of Vibrio vulnificus capsular polysaccharide. Infect Immun (1999) 1.36
Identification of genetic loci required for capsular expression in Vibrio vulnificus. Infect Immun (2003) 1.28
Genetic variation in the Vibrio vulnificus group 1 capsular polysaccharide operon. J Bacteriol (2006) 1.23
Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect Immun (1997) 1.15
Preliminary structure determination of the capsular polysaccharide of Vibrio cholerae O139 Bengal Al1837. J Bacteriol (1995) 0.98
Immunogenicity of Vibrio vulnificus capsular polysaccharides and polysaccharide-protein conjugates. Infect Immun (1993) 0.92
Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine model. Infect Immun (1995) 0.90
Identification of the Vibrio vulnificus wbpP gene and evaluation of its role in virulence. Infect Immun (2006) 0.90
Thermal-death times of opaque and translucent morphotypes of Vibrio vulnificus. Appl Environ Microbiol (1997) 0.88
The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor. Infect Immun (2007) 0.86
Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus. Infect Immun (1996) 0.86
The fur-iron complex modulates expression of the quorum-sensing master regulator, SmcR, to control expression of virulence factors in Vibrio vulnificus. Infect Immun (2013) 0.82
A gliding bacterium strain inhibits adhesion and motility of another gliding bacterium strain in a marine biofilm Appl Environ Microbiol (1998) 0.81
In vitro biosynthesis and chemical identification of UDP-N-acetyl-d-quinovosamine (UDP-d-QuiNAc). J Biol Chem (2014) 0.81
Cyclo(Phe-Pro) produced by the human pathogen Vibrio vulnificus inhibits host innate immune responses through the NF-κB pathway. Infect Immun (2015) 0.77
Cyclic AMP and cyclic AMP-receptor protein modulate the autoinducer-2-mediated quorum sensing system in Vibrio vulnificus. Curr Microbiol (2012) 0.77
Effects of Pyrogallol on Growth and Cytotoxicity of Wild-Type and katG Mutant Strains of Vibrio vulnificus. PLoS One (2016) 0.75
Utilization of bench-stable and readily available nickel(II) triflate for access to 1,2-cis-2-aminoglycosides. Carbohydr Res (2016) 0.75
Temperature Change Induces the Expression of vuuA Encoding Vulnibactin Receptor and crp Encoding Cyclic AMP Receptor Protein in Vibrio vulnificus. Curr Microbiol (2016) 0.75
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med (1979) 10.57
Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun (1983) 7.26
Stoichiometric depolymerization of polyuronides and glycosaminoglycuronans to monosaccharides following reduction of their carbodiimide-activated carboxyl groups. Biochemistry (1972) 5.79
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis (1988) 5.30
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Distribution of Vibrio vulnificus and other lactose-fermenting vibrios in the marine environment. Appl Environ Microbiol (1983) 4.30
Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med (1988) 4.11
Correlation between virulence and colony morphology in Vibrio vulnificus. Infect Immun (1987) 3.93
Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect Immun (1985) 3.69
Virulent strains of Vibrio vulnificus isolated from estuaries of the United States West Coast. Appl Environ Microbiol (1987) 3.60
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun (1990) 3.47
Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. J Exp Med (1979) 2.89
Structure and biosynthesis of the capsular antigens of Escherichia coli. Curr Top Microbiol Immunol (1990) 2.64
Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus. Infect Immun (1985) 2.60
The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol (1990) 2.18
Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness. Infect Immun (1982) 1.98
Purification and characterization of an elastolytic protease of Vibrio vulnificus. J Gen Microbiol (1987) 1.97
Genetics of capsular polysaccharide production in bacteria. Curr Top Microbiol Immunol (1990) 1.96
Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera. Infect Immun (1984) 1.95
The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun (1991) 1.87
Extracellular phospholipase A2 and lysophospholipase produced by Vibrio vulnificus. Infect Immun (1984) 1.65
Identification of Vibrio vulnificus O serovars with antilipopolysaccharide monoclonal antibody. J Clin Microbiol (1991) 1.53
Characterization of the Salmonella paratyphi C Vi polysaccharide. Infect Immun (1989) 1.37
Characterization of a polysaccharide component of lipopolysaccharide from Pseudomonas aeruginosa IID 1008 (ATCC 27584) as D-rhamnan. Eur J Biochem (1987) 1.30
Outer membrane polysaccharide deficiency in two nongliding mutants of Cytophaga johnsonae. J Bacteriol (1990) 1.26
On the serology of Vibrio vulnificus. Jpn J Med Sci Biol (1985) 1.19
Complete structure of the polysaccharide from Streptococcus sanguis J22. Biochemistry (1990) 1.17
Complete structure of the cell surface polysaccharide of Streptococcus oralis C104: a 600-MHz NMR study. Biochemistry (1991) 1.08
Complete structure of the cell surface polysaccharide of Streptococcus oralis ATCC 10557: a receptor for lectin-mediated interbacterial adherence. Biochemistry (1991) 1.04
Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated). Infect Immun (1991) 0.94
The structure of the O-polysaccharide from Pseudomonas aeruginosa IID 1009 (ATCC 27585). J Biochem (1989) 0.83
The structure of the O-specific chain of lipopolysaccharide from Pseudomonas aeruginosa IID 1012 (ATCC 27588). J Biochem (1989) 0.81
Cholera. Clin Microbiol Rev (1995) 12.33
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med (1995) 5.69
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Bacteriophage therapy. Antimicrob Agents Chemother (2001) 5.16
Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J Magn Reson B (1995) 4.93
Oxygen and the growth and metabolism of Clostridium acetobutylicum. J Gen Microbiol (1971) 4.91
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun (1981) 4.42
Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev (1996) 4.09
Coronary artery fistulas in adults: incidence, angiographic characteristics, natural history. Cathet Cardiovasc Diagn (1995) 3.94
Macrophages as a source of HIV during opportunistic infections. Science (1997) 3.92
A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature (1999) 3.89
Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatry (1988) 3.47
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun (1990) 3.47
Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect Immun (1992) 3.30
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun (2002) 3.14
Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates. Lancet (1998) 3.03
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
Pupillary signs in diabetic autonomic neuropathy. Br Med J (1978) 2.79
A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health (1996) 2.78
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Evaluation of DNA colony hybridization and other techniques for detection of virulence in Yersinia species. J Clin Microbiol (1989) 2.58
Production of Solvents by Clostridium acetobutylicum Cultures Maintained at Neutral pH. Appl Environ Microbiol (1984) 2.51
Back pain: a randomized clinical trial of rotational manipulation of the trunk. Br J Ind Med (1974) 2.47
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun (1995) 2.45
Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect Immun (1985) 2.42
Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. J Clin Invest (1995) 2.41
Lord Bradley's review of people with mental health or learning disabilities in the criminal justice system in England: All not equal in the eyes of the law? Int J Prison Health (2009) 2.33
On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridium pasteurianum. Biochem Biophys Res Commun (1981) 2.32
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17
Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet (1999) 2.12
Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol (1996) 2.10
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry (1999) 2.07
Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis (1988) 2.07
Half-time and high-speed running in the second half of soccer. Int J Sports Med (2012) 2.03
Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol (1996) 2.01
Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains. J Clin Microbiol (1986) 1.96
Utilization of L-threonine by a species of Arthrobacter. A novel catabolic role for "aminoacetone synthase". Biochem J (1969) 1.95
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol (1993) 1.94
Identification of environmental Vibrio vulnificus isolates with a DNA probe for the cytotoxin-hemolysin gene. Appl Environ Microbiol (1987) 1.94
Theatre air sampling--ignorance is bliss! J Hosp Infect (1995) 1.91
The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun (1991) 1.87
Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun (1992) 1.86
Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159:H4. Infect Immun (1987) 1.86
Superoxide dismutase in some obligately anaerobic bacteria. FEBS Lett (1975) 1.85
The cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio cholerae E1 Tor hemolysin gene. Infect Immun (1990) 1.79
Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J (1994) 1.76
Facial sweating in Horner's syndrome. Brain (1984) 1.73
Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J Clin Microbiol (1992) 1.71
Investigation of an outbreak of Salmonella enteritidis gastroenteritis associated with consumption of eggs in a restaurant chain in Maryland. Am J Epidemiol (1988) 1.71
Molecular techniques in the study of Salmonella typhi in epidemiologic studies in endemic areas: comparison with Vi phage typing. Am J Trop Med Hyg (1986) 1.68
Seroprevalence of Helicobacter pylori in Seventh-Day Adventists and other groups in Maryland. Lack of association with diet. Arch Intern Med (1990) 1.68
Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol (2000) 1.66
Cholera in Lima, Peru, correlates with prior isolation of Vibrio cholerae from the environment. Am J Epidemiol (1997) 1.65
Vibrio metschnikovii bacteremia in a patient with cholecystitis. J Clin Microbiol (1981) 1.65
Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis (1993) 1.59
Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun (2001) 1.58
Effect of metronidazole on hydrogen production by Clostridium acetobutylicum. Arch Mikrobiol (1972) 1.57
Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East. J Clin Microbiol (1993) 1.57
A polysaccharide from Streptococcus sanguis 34 that inhibits coaggregation of S. sanguis 34 with Actinomyces viscosus T14V. J Bacteriol (1988) 1.57
Daily energy expenditure in Mexican and USA Pima indians: low physical activity as a possible cause of obesity. Int J Obes Relat Metab Disord (2000) 1.55
Spo0A directly controls the switch from acid to solvent production in solvent-forming clostridia. Mol Microbiol (2000) 1.55
Structure and dynamics of a denatured 131-residue fragment of staphylococcal nuclease: a heteronuclear NMR study. Biochemistry (1994) 1.55
Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers. J Med Chem (1998) 1.53
Mutations in the extracellular protein secretion pathway genes (eps) interfere with rugose polysaccharide production in and motility of Vibrio cholerae. Infect Immun (2000) 1.50
The neuropsychology of de novo patients with idiopathic Parkinson's disease: the effects of age of onset. Int J Neurosci (1989) 1.49
Structural and antigenic types of cell wall polysaccharides from viridans group streptococci with receptors for oral actinomyces and streptococcal lectins. Infect Immun (1997) 1.49
Detection by immune electron microscopy of 27-nm viral particles associated with community-acquired diarrhea in children. J Infect Dis (1990) 1.48
Capsular types of Vibrio vulnificus: an analysis of strains from clinical and environmental sources. J Infect Dis (1993) 1.47
NMR docking of a substrate into the X-ray structure of staphylococcal nuclease. Proteins (1992) 1.46
Lectin recognition of host-like saccharide motifs in streptococcal cell wall polysaccharides. Glycobiology (1995) 1.46
Use of colistin-polymyxin B-cellobiose agar for isolation of Vibrio vulnificus from the environment. Appl Environ Microbiol (1992) 1.45
Persistence of cholera in the United States: isolation of Vibrio cholerae O1 from a patient with diarrhea in Maryland. J Clin Microbiol (1986) 1.44
Structure of ten free N-glycans in ripening tomato fruit. Arabinose is a constituent of a plant N-glycan. Plant Physiol (1993) 1.43
Chlorine and survival of "rugose" Vibrio cholerae. Lancet (1992) 1.43
Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine. Infect Immun (1994) 1.43
Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis (2007) 1.43
Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science (1987) 1.42
Evidence for progression from mild to severe mitral regurgitation in mitral valve prolapse. Am J Cardiol (1986) 1.42
Handcuff neuropathy involving the dorsal ulnar cutaneous nerve. Muscle Nerve (1993) 1.40
An outbreak of cholera in Maryland associated with imported commercial frozen fresh coconut milk. J Infect Dis (1993) 1.39
Standard effective doses for proliferative tumours. Phys Med Biol (1999) 1.39
Confusion, cortical blindness and fever. Med J Aust (1995) 1.38
The biosynthesis of granulose by Clostridium pasteurianum. Biochem J (1974) 1.37
Phylogeny of Vibrio cholerae based on recA sequence. Infect Immun (2000) 1.37